Insight into dsm-firmenich's Recent Share Repurchase Activities
dsm-firmenich, a recognized leader in the realms of nutrition, health, and beauty, is taking significant steps to enhance shareholder value through its strategic share repurchase program. Initiated in early 2025, the company aims to repurchase ordinary shares worth €1 billion to cover compensation plans and to reduce its capital, indicating a strong commitment to maintaining robust financial health.
Beginning of the Share Repurchase Program
The journey began on February 13, 2025, when dsm-firmenich announced its intention to repurchase shares worth €1 billion. This ambitious plan started with an initial repurchase phase totaling €500 million. The company kicked off this program on April 1, 2025. Of this amount, €80 million was specifically allocated to address commitments under the company’s share-based compensation plans, while the remaining €500 million was focused on capital reduction.
Increasing the Scope of the Program
As the program progressed, dsm-firmenich reviewed its capital management strategies and decided to expand the scope of the repurchase initiative. On June 27, 2025, the company announced an increase in the share repurchase plan to €1,080 million, a notable adjustment following the successful sale of its stake in the Feed Enzymes Alliance. This move demonstrates the company's proactive approach to ensuring that it capitalizes on profitable divestitures.
Recent Developments in Share Repurchases
In a recent update, the company communicated to the market that during the period from August 18 to August 22, 2025, it repurchased a total of 190,732 shares at an average price of €84.11, amounting to €16.0 million. This brings the grand total of shares repurchased under this program to 6,999,485 shares at an average price of €90.75, culminating in an overall expenditure of €635.2 million.
Timeline for Completion of the Share Repurchase Program
dsm-firmenich is dedicated to completing this comprehensive €1,080 million share repurchase program by January 30, 2026. This timeline not only reflects the company’s commitment to its shareholders but also signals a confident financial outlook as it seeks to optimize its capital structure.
Contact and Company Overview
For further insights and information regarding dsm-firmenich, interested parties can reach out via email:
Investor Relations:
Email: investors@dsm-firmenich.com
Media Inquiries:
Email: media@dsm-firmenich.com
About dsm-firmenich: As innovators, dsm-firmenich is dedicated to creating essential and appealing products across various industries such as nutrition and beauty. With operations in nearly 60 countries, the company boasts an impressive revenue exceeding €12 billion, supported by a diverse workforce of around 30,000 employees. Emphasizing sustainability and innovation, dsm-firmenich continues to drive progress and cater to the evolving needs of global consumers.
Frequently Asked Questions
What is the main goal of dsm-firmenich's share repurchase program?
The main aim is to enhance shareholder value by repurchasing shares to cover employee compensation plans and reduce the company's capital.
How much did dsm-firmenich plan to repurchase initially?
The company initially planned to repurchase €1 billion worth of ordinary shares, starting with an initial €500 million allocation.
When did the share repurchase program officially commence?
The share repurchase program officially started on April 1, 2025.
How many shares have been repurchased under the program so far?
As of now, a total of 6,999,485 shares have been repurchased at an average price of €90.75.
What is the expected completion date for the share repurchase program?
The program is expected to be completed by January 30, 2026.
